Pall Corporation announced today that it has acquired the BioSMB technology platform from Tarpon Biosystems. The addition of Tarpon’s cutting-edge technology with Pall’s engineering capabilities and innovative single use technologies will accelerate the adoption of continuous downstream processing into biopharmaceutical manufacturing. The BioSMB chromatographic systems enable single use, multi-column chromatography for process development and are well placed for multi-product and single use facilities. The addition of the BioSMB technology expands Pall’s portfolio in continuous processing technology at both the process…